Literature DB >> 31331930

Recurrent fetal hydrops with maternal M alloimmunisation: not a benign condition.

Michelle Yu1, Kathryn Graham1, Leonardo Pasalic2, Thushari Indika Alahakoon3.   

Abstract

Haemolytic disease of the fetus and newborn (HDFN) is associated with red cell antibodies. Anti-M usually results in a mild haemolysis and is rarely clinically significant. There is no established consensus on management of pregnancies with anti-M. A case of recurrent HDFN with maternal M alloimmunisation was identified at a tertiary hospital in Australia. We collected the patient and neonate's clinical and pathological data and interpreted the case with available literature. This is the first case in literature of recurrent fetal hydrops in the setting of M alloimmunisation. Neonate was delivered in a poor condition, intubated and admitted to the neonatal intensive care unit for ionotropic support, red cell transfusion and plasma transfusion for coagulopathy. Direct Coombs test was positive, confirming HDFN. Although anti-M rarely causes HDFN, accurate history, fetal surveillance and monitoring is essential for identification of fetal anaemia. Concurrent placental disease may increase fetal risk from anti-M antibodies. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  haematology (incl blood transfusion); pregnancy

Mesh:

Substances:

Year:  2019        PMID: 31331930      PMCID: PMC6664319          DOI: 10.1136/bcr-2019-230552

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions.

Authors:  Giancarlo Mari; Roland Zimmermann; Kenneth J Moise; Russell L Deter
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

2.  Hydrops fetalis and intrauterine deaths due to anti-M.

Authors:  T Kanra; K Yüce; I U Ozcebe
Journal:  Acta Obstet Gynecol Scand       Date:  1996-04       Impact factor: 3.636

Review 3.  Management and prevention of red cell alloimmunization in pregnancy: a systematic review.

Authors:  Kenneth J Moise; Pedro S Argoti
Journal:  Obstet Gynecol       Date:  2012-11       Impact factor: 7.661

4.  Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.

Authors:  Agneta Wikman; Ann Edner; Gunilla Gryfelt; Baldvin Jonsson; Jan-Inge Henter
Journal:  Transfusion       Date:  2007-05       Impact factor: 3.157

5.  Anti-M antibody in pregnancy.

Authors:  D J Thompson; D Z Stults; S J Daniel
Journal:  Obstet Gynecol Surv       Date:  1989-09       Impact factor: 2.347

Review 6.  Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature.

Authors:  Hiroyasu Yasuda; Hitoshi Ohto; Kenneth E Nollet; Kinuyo Kawabata; Shunnichi Saito; Yoshihito Yagi; Yutaka Negishi; Atsushi Ishida
Journal:  Transfus Med Rev       Date:  2013-10-19

7.  Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.

Authors:  J M Koelewijn; T G M Vrijkotte; C E van der Schoot; G J Bonsel; M de Haas
Journal:  Transfusion       Date:  2008-02-01       Impact factor: 3.157

8.  Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twins.

Authors:  Satyam Arora; Veena Doda; Arti Maria; Urvershi Kotwal; Saurabh Goyal
Journal:  Asian J Transfus Sci       Date:  2015 Jan-Jun

9.  Anti-M Alloimmunization: Management and Outcome at a Single Institution.

Authors:  Bethany Stetson; Scott Scrape; Kara Beth Markham
Journal:  AJP Rep       Date:  2017-11-22

10.  Severe hemolytic disease of the newborn caused by anti-m antibodies.

Authors:  Eduardo Alfredo Duro; Liliana Desalvo; Sandra Kuret
Journal:  Iran J Pediatr       Date:  2013-10       Impact factor: 0.364

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.